| CRISPR-STOP: gene silencing through base-editing-induced nonsense mutations C Kuscu, M Parlak, T Tufan, J Yang, K Szlachta, X Wei, R Mammadov, ... Nature methods 14 (7), 710-712, 2017 | 367 | 2017 |
| Live cell imaging of low-and non-repetitive chromosome loci using CRISPR-Cas9 P Qin, M Parlak, C Kuscu, J Bandaria, M Mir, K Szlachta, R Singh, ... Nature communications 8 (1), 14725, 2017 | 229 | 2017 |
| Ubiquitin modification by the E3 ligase/ADP-ribosyltransferase Dtx3L/Parp9 CS Yang, K Jividen, A Spencer, N Dworak, L Ni, LT Oostdyk, M Chatterjee, ... Molecular cell 66 (4), 503-516. e5, 2017 | 174 | 2017 |
| Small molecule inhibitor of CBFβ-RUNX binding for RUNX transcription factor driven cancers A Illendula, J Gilmour, J Grembecka, VSS Tirumala, A Boulton, ... EBioMedicine 8, 117-131, 2016 | 108 | 2016 |
| CD74 signaling links inflammation to intestinal epithelial cell regeneration and promotes mucosal healing L Farr, S Ghosh, N Jiang, K Watanabe, M Parlak, R Bucala, S Moonah Cellular and molecular gastroenterology and hepatology 10 (1), 101-112, 2020 | 44 | 2020 |
| A novel method for covalent immobilization of dextransucrase M Parlak, D Ustek, A Tanriseven Journal of Molecular Catalysis B: Enzymatic 89, 52-60, 2013 | 31 | 2013 |
| A genome-wide analysis of lentivector integration sites using targeted sequence capture and next generation sequencing technology D Ustek, S Sirma, E Gumus, M Arikan, A Cakiris, N Abaci, J Mathew, ... Infection, Genetics and Evolution 12 (7), 1349-1354, 2012 | 24 | 2012 |
| The barrier molecules junction plakoglobin, filaggrin, and dystonin play roles in melanoma growth and angiogenesis KM Leick, AB Rodriguez, MM Melssen, M Benamar, RS Lindsay, R Eki, ... Annals of surgery 270 (4), 712-722, 2019 | 22 | 2019 |
| Modulation of NKG2D, NKp46, and Ly49C/I facilitates natural killer cell-mediated control of lung cancer L Shi, K Li, Y Guo, A Banerjee, Q Wang, UM Lorenz, M Parlak, ... Proceedings of the National Academy of Sciences 115 (46), 11808-11813, 2018 | 22 | 2018 |
| Epigenetic States of nephron progenitors and epithelial differentiation M Adli, M Parlak, Y Li, SS El‐Dahr Journal of cellular biochemistry 116 (6), 893-902, 2015 | 21 | 2015 |
| Designing of a novel dextransucrase efficient in acceptor reactions M Parlak, D Ustek, A Tanriseven Carbohydrate research 386, 41-47, 2014 | 21 | 2014 |
| A robust CRISPR–Cas9-based fluorescent reporter assay for the detection and quantification of DNA double-strand break repair R Eki, J She, M Parlak, M Benamar, KP Du, P Kumar, T Abbas Nucleic Acids Research 48 (21), e126-e126, 2020 | 16 | 2020 |
| Deacetylation as a receptor-regulated direct activation switch for pannexin channels YH Chiu, CB Medina, CA Doyle, M Zhou, AK Narahari, JK Sandilos, ... Nature communications 12 (1), 4482, 2021 | 15 | 2021 |
| The role of tyrosine phosphatase SHP-1 in regulatory T cell function and immune tolerance QL Gu, M Parlak, U Lorenz The Journal of Immunology 206 (1_Supplement), 25.07-25.07, 2021 | 1 | 2021 |
| Corrigendum to:“Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers”[EBioMedicine 8 (2016) 117–131] A Illendula, J Gilmour, J Grembecka, VSS Tirumala, A Boulton, ... EBioMedicine 25, 188, 2017 | | 2017 |
| Multicolor labeling and imaging nuclear organization of native chromatin loci with type II CRISPR/Cas9 system in living cells P Qin, M Parlak, J Bandaria, A Yildiz, A Mazhar MOLECULAR BIOLOGY OF THE CELL 27, 2016 | | 2016 |
